サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：接続型ドラッグデリバリーデバイスの市場規模、シェア、動向分析レポート：製品別、投与経路別（非経口、吸入）、用途別（喘息、COPD、糖尿病管理、その他）、地域別、セグメント別予測、2023年～2030年
市場調査レポート
商品コード
1170997

接続型ドラッグデリバリーデバイスの市場規模、シェア、動向分析レポート：製品別、投与経路別（非経口、吸入）、用途別（喘息、COPD、糖尿病管理、その他）、地域別、セグメント別予測、2023年～2030年

Connected Drug Delivery Devices Market Size, Share & Trends Analysis Report By Product, By Route Of Administration (Parenteral, Inhalational), By Application (Asthma, COPD, Diabetes Management, Others), By Region, And Segment Forecasts, 2023 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 150 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.76円
接続型ドラッグデリバリーデバイスの市場規模、シェア、動向分析レポート：製品別、投与経路別（非経口、吸入）、用途別（喘息、COPD、糖尿病管理、その他）、地域別、セグメント別予測、2023年～2030年
出版日: 2022年11月16日
発行: Grand View Research
ページ情報: 英文 150 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

接続型ドラッグデリバリーデバイスの市場成長・動向

グランドビューリサーチ社の最新レポートによると、接続型ドラッグデリバリーデバイスの世界市場規模は、2030年までに256億3000万米ドルに達すると予測されています。同市場は、2023年から2030年にかけて23.45%という有利なCAGRで拡大すると予測されています。市場成長の主な要因としては、患者の服薬アドヒアランスを高める必要性、研究開発イニシアティブ、遠隔デジタルモニタリングの加速などが挙げられます。例えば2022年9月、YpsomedはSidekick Healthと提携し、Sidekickの既知のデジタル治療薬ソリューションに自己注射モジュールを組み込んで、YpsomedのデバイスとSmartServicesの提供を拡大しました。これにより、慢性疾患の患者は、イプソメド社のデバイスとサイドキック社のデジタルヘルス行動経済学とゲーミフィケーションの専門知識の統合により、パーソナライズされた患者体験を受けることができ、製薬会社の顧客は、総合サービス、および先進のデジタル治療管理システムから利益を得ることができると思われます。

技術的な進歩の1つは、接続型ドラッグデリバリーで、センサーを搭載し、携帯電話、Bluetooth、NFC（Near Field Communication）ネットワークでサーバーやアプリとの通信やデータ転送を可能にするものです。これらの接続型・ドラック・デリバリーの主な利点の一つは、患者にリマインダーやアドヒアランス・トラッカーを提供し、処方された薬のスケジュールを遵守するために必要な労力を軽減することです。これにより、処方箋の無駄、特に保険診療が必要な生物学的注射薬の無駄をさらに削減することができます。さらに医師は、接続型・ドラック・デリバリー・システムによって、患者が推奨された治療法をどの程度守っているかをモニタリングし、必要に応じて患者の治療を変更することができます。例えば、糖尿病や喘息などの慢性疾患を持つ患者のセルフメディケーションを管理するのに、接続型ドラッグデリバリーデバイスは有効です。今後数年間は、これらの要因が市場の成長を加速させると予想されます。

COPD、糖尿病、喘息などの慢性疾患の世界の上昇率は、接続型ドラッグデリバリーデバイスのビジネスを推進すると予想されます。例えば、国立医学図書館と国立生物工学情報センターが2022年1月に発表した2021年の糖尿病有病率の推定に関する調査によると、2021年の20歳から79歳までの疾病有病率は10.5％と推定され、2045年には12.2％に増加する可能性があります。糖尿病は、男女ともに等しく罹患すると考えられていますが、75歳から79歳の方に最も多くみられます。また、より優れた利点を持つ接続型ドラッグデリバリーデバイスの普及に伴い、手動式の薬剤投与デバイスがますます置き換えられてきています。これらの要因は、接続型ドラッグ市場の成長を促進すると予想されます。

世界のCOVID-19の大流行が悪影響を及ぼし、ヘルスケアサービスの必要性が高まっています。これは、改善された支援と技術の迅速な成長のためにヘルスケアシステムを再設計する傾向を加速しています。2020年、ほとんどの世界市場が下降する中、この市場は困難な状況やほとんどの国でのロックダウンにもかかわらず、前例のない成長を見せました。ロックダウンの制限により、在宅ケアで使用するドラッグデリバリーシステムの需要が予想外に高まり、接続型ドラッグデリバリーデバイスの需要も増加したのです。

当レポート「接続型ドラッグデリバリーデバイスの市場規模、シェア＆動向分析レポート、製品別（接続型センサー、統合接続型デバイス）、投与経路別（非経口、吸入）、用途別（喘息、COPD、糖尿病管理）、地域別、およびセグメント予測、2022-2030」は、現在グランドビュー・リサーチ社の顧客向けに販売中、以下からも直接購入が可能です。

接続型ドラッグデリバリーデバイス市場のレポートハイライト

2022年の世界市場は48億4000万米ドルで、予測期間中に23.45%のCAGRで成長すると予測される

スタンドアロンコンポーネントおよびソフトウェアセグメントは、従来のドラッグデリバリー機器を通常の機能を妨げることなく接続型ドラッグデリバリー機器に変換し、機器が使い捨てであっても再利用できる接続型センサーに対する需要の増加により、予測期間中に最も高い収益シェアを獲得すると予想される

スマート＆接続型非経口デバイスが従来のものと比較して提供する数多くの利点により、非経口セグメントは予測期間中に市場の成長を牽引すると予想されます。

糖尿病管理は2022年に36.23%超のシェアを獲得し、市場を独占しました。これは、糖尿病の有病率の上昇、技術的進歩、インスリン送達デバイスの研究開発などの要因によるものです。

予測期間中、北米が市場を独占すると予想されます。これは、この地域の一人当たりのヘルスケア支出が高いこと、主要企業の技術プレゼンスが急速に普及していること、服薬アドヒアランスのための遠隔モニタリングの採用が拡大していることなどに起因します。

目次

第1章 調査手法と範囲

  • 市場セグメンテーションと範囲
    • 推定・予測のタイムライン
  • 調査手法
  • 情報調達
    • 購入したデータベース：
    • GVRの内部データベース
    • 二次情報
    • 1次調査：
    • 1次調査内容
  • 情報またはデータ分析
    • データ分析モデル
  • 市場の策定と検証
  • モデルの詳細
    • コモディティフロー分析
  • 二次情報一覧
  • 目的

第2章 エグゼクティブサマリー

  • 市場のスナップショット
  • セグメントのスナップショット
  • 競合情勢のスナップショット

第3章 接続型ドラッグデリバリーデバイス市場：市場変数の動向と範囲

  • 市場系列の見通し
    • 親市場分析
    • 補助的な市場分析
  • 浸透と成長の見通しのマッピング
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
    • 市場機会分析
    • 市場課題分析
  • 業界分析
    • ポーターのファイブフォース分析
      • 買い手の交渉力
      • 供給企業の交渉力
      • 新規参入業者の脅威
      • 代替品の脅威
      • 業界の競争率：高
    • PESTEL分析
      • 政治と法律の情勢
      • 経済・社会情勢
      • 環境情勢
      • テクノロジー情勢
  • 研究開発・製品パイプライン分析
  • 価格分析
  • 規制および償還の枠組み
  • 接続型ドラッグデリバリーデバイス市場：COVID-19影響分析

第4章 接続型ドラッグデリバリーデバイス市場：製品分析

  • 製品市場シェア分析、2022年および2030年
  • 接続型ドラッグデリバリーデバイス市場：製品変動分析、2018年から2030年
    • スタンドアロンコンポーネントとソフトウェア
    • 統合デバイス

第5章 接続型ドラッグデリバリーデバイス市場：投与経路分析

  • 投与経路の市場シェア分析、2022年および2030年
  • 接続型ドラッグデリバリーデバイス市場：投与経路の変動分析、2018年から2030年
    • 非経口
    • 吸入

第6章 接続型ドラッグデリバリーデバイス市場：アプリケーション分析

  • アプリケーション市場シェア分析、2022年および2030年
  • 接続型ドラッグデリバリーデバイス市場：アプリケーションの変動分析、2018年から2030年
    • 喘息
    • COPD
    • 糖尿病管理
    • その他

第7章 接続型ドラッグデリバリーデバイス市場：地域市場分析、製品別、投与経路、アプリケーション、流通チャネル2018年から2030年（100万米ドル）

  • 地域市場シェア分析、2022年および2030年
  • 地域市場のスナップショット
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • MEA
    • 南アフリカ
    • サウジアラビア

第8章 接続型ドラッグデリバリーデバイス市場-競合分析

  • Teva Respiratory, Llc
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Novo Nordisk A/S
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Phillips-Medisize, Llc
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Medtronic
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Adherium Limited
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Tandem Diabetes Care, Inc.
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Biocorp
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Propeller Health
    • 会社概要
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Ypsomed Ag
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Aptar Pharma
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • 市場参加の分類
  • 企業の市況分析
  • 主要企業一覧
図表

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of key companies
  • Table 3 North America Connected Drug Delivery Devices market, by country, 2018 - 2030 (USD Million)
  • Table 4 North America Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
  • Table 5 North America Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 6 North America Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
  • Table 7 U.S. Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
  • Table 8 U.S. Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 9 U.S. Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
  • Table 10 Canada Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
  • Table 11 Canada Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 12 Canada Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
  • Table 13 Europe Connected Drug Delivery Devices market, by country, 2018 - 2030 (USD Million)
  • Table 14 Europe Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
  • Table 15 Europe Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 16 Europe Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
  • Table 17 U.K. Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
  • Table 18 U.K. America Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 19 U.K. Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
  • Table 20 Germany Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
  • Table 21 Germany Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 22 Germany Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
  • Table 23 France Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
  • Table 24 France Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 25 France Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
  • Table 26 Italy Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
  • Table 27 Italy Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 28 Italy Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
  • Table 29 Spain Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
  • Table 30 Spain Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 31 Spain Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
  • Table 32 Asia Pacific Connected Drug Delivery Devices market, by country, 2018 - 2030 (USD Million)
  • Table 33 Asia Pacific Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
  • Table 34 Asia Pacific Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 35 Asia Pacific Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
  • Table 36 China Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
  • Table 37 China Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 38 China Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
  • Table 39 Japan Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
  • Table 40 Japan Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 41 Japan Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
  • Table 42 India Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
  • Table 43 India Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 44 India Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
  • Table 45 Australia Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
  • Table 46 Australia Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 47 Australia Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
  • Table 48 South Korea Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
  • Table 49 South Korea Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 50 South Korea Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
  • Table 51 LATAM Connected Drug Delivery Devices market, by country, 2018 - 2030 (USD Million)
  • Table 52 LATAM Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
  • Table 53 LATAM Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 54 LATAM Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
  • Table 55 Brazil Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
  • Table 56 Brazil Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 57 Brazil Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
  • Table 58 Mexico Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
  • Table 59 Mexico Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 60 Mexico Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
  • Table 61 Argentina Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
  • Table 62 Argentina Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 63 Argentina Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
  • Table 64 MEA Connected Drug Delivery Devices market, by country, 2018 - 2030 (USD Million)
  • Table 65 MEA Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
  • Table 66 MEA Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 67 MEA Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
  • Table 68 South Africa Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
  • Table 69 South Africa Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 70 South Africa Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
  • Table 71 Saudi Arabia Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
  • Table 72 Saudi Arabia Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 73 Saudi Arabia Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
  • Table 74 Global Connected Drug Delivery Devices market, by region, 2018 - 2030 (USD Million)
  • Table 75 Global Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
  • Table 76 Global Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 77 Global Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Commodity flow analysis
  • Fig. 10 Penetration & growth prospect mapping
  • Fig. 11 Market trends & outlook
  • Fig. 12 Market driver relevance analysis (Current & future impact)
  • Fig. 13 Market restraint relevance analysis (Current & future impact)
  • Fig. 14 Connected Drug Delivery Devices Market product outlook: Key takeaways
  • Fig. 15 Connected Drug Delivery Devices Market: Product movement analysis
  • Fig. 16 Global Standalone components & software market 2018 - 2030 (USD Million)
  • Fig. 17 Global Integrated devices market 2018 - 2030 (USD Million)
  • Fig. 18 Connected Drug Delivery Devices Market Route of Administration outlook: Key takeaways
  • Fig. 19 Connected Drug Delivery Devices Market: Route of Administration movement analysis
  • Fig. 20 Global Parenteral market 2018 - 2030 (USD Million)
  • Fig. 21 Global Inhalational market 2018 - 2030 (USD Million)
  • Fig. 22 Connected Drug Delivery Devices Market Application outlook: Key takeaways
  • Fig. 23 Connected Drug Delivery Devices Market: Application movement analysis
  • Fig. 24 Global Asthma market 2018 - 2030 (USD Million)
  • Fig. 25 Global COPD market 2018 - 2030 (USD Million)
  • Fig. 26 Global Diabetes Management market 2018 - 2030 (USD Million)
  • Fig. 27 Global Others market 2018 - 2030 (USD Million)
  • Fig. 28 Regional outlook, 2022 & 2030
  • Fig. 29 Regional marketplace: Key takeaways
  • Fig. 30 North America Connected Drug Delivery Devices Market by countries, 2018 - 2030 (USD Million)
  • Fig. 31 U.S. Connected Drug Delivery Devices market, 2018 - 2030 (USD Million)
  • Fig. 32 Canada Connected Drug Delivery Devices market, 2018 - 2030 (USD Million)
  • Fig. 33 Europe Connected Drug Delivery Devices market by countries, 2018 - 2030 (USD Million)
  • Fig. 34 U.K. Connected Drug Delivery Devices market, 2018 - 2030 (USD Million)
  • Fig. 35 Germany Connected Drug Delivery Devices market, 2018 - 2030 (USD Million)
  • Fig. 36 France Connected Drug Delivery Devices market, 2018 - 2030 (USD Million)
  • Fig. 37 Spain Connected Drug Delivery Devices market, 2018 - 2030 (USD Million)
  • Fig. 38 Italy Connected Drug Delivery Devices market, 2018 - 2030 (USD Million)
  • Fig. 39 Asia Pacific Connected Drug Delivery Devices market by countries, 2018 - 2030 (USD Million)
  • Fig. 40 China Connected Drug Delivery Devices market, 2018 - 2030 (USD Million)
  • Fig. 41 India Connected Drug Delivery Devices market, 2018 - 2030 (USD Million)
  • Fig. 42 Australia Connected Drug Delivery Devices market, 2018 - 2030 (USD Million)
  • Fig. 43 South Korea Connected Drug Delivery Devices market, 2018 - 2030 (USD Million)
  • Fig. 44 Japan Connected Drug Delivery Devices market, 2018 - 2030 (USD Million)
  • Fig. 45 Latin America Connected Drug Delivery Devices market by countries, 2018 - 2030 (USD Million)
  • Fig. 46 Brazil Connected Drug Delivery Devices market, 2018 - 2030 (USD Million)
  • Fig. 47 Mexico Connected Drug Delivery Devices market, 2018 - 2030 (USD Million)
  • Fig. 48 Argentina Connected Drug Delivery Devices market, 2018 - 2030 (USD Million)
  • Fig. 49 MEA Connected Drug Delivery Devices market by countries, 2018 - 2030 (USD Million)
  • Fig. 50 South Africa Connected Drug Delivery Devices market, 2018 - 2030 (USD Million)
  • Fig. 51 Saudi Arabia Connected Drug Delivery Devices market, 2018 - 2030 (USD Million)
  • Fig. 52 Market Participant categorization
  • Fig. 53 Company market position analysis
目次
Product Code: GVR-2-68038-651-6

Connected Drug Delivery Devices Market Growth & Trends

The global connected drug delivery devices market size is expected to reach USD 25.63 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a lucrative CAGR of 23.45% from 2023 to 2030. Key factors driving the market growth include the need to increase patient medication adherence, R&D initiatives, and the acceleration of remote digital monitoring. In September 2022, Ypsomed for instance, partnered with Sidekick Health to expand Ypsomed's device and SmartServices offering by incorporating a self-injection module into Sidekick's known digital therapeutics solution. Through this, patients with chronic diseases are likely to receive a personalized patient experience due to the integration of Ypsomed's devices with Sidekick's digital health behavioral economics and gamification expertise, and pharmaceutical customers will benefit from a comprehensive service, and leading digital therapy management system.

One of the technological advancements is connected drug delivery, which has a sensor that enables communication and data transfer to servers and apps over cellular, Bluetooth, and Near Field Communication (NFC) networks. One of the main benefits of these connected drug delivery systems is that it gives patients reminders and adherence trackers, reducing the effort needed to comply with the prescribed medication schedule. This further reduces the cost of prescription waste, especially that from the increasingly popular biological injectable drugs that insurance would be required to pay for. Additionally, doctors can monitor how well their patients are adhering to their recommended therapies owing to connected drug delivery systems and change the patient's care as appropriate. For instance, connected drug delivery devices can be beneficial to manage self-medication in persons with chronic diseases like diabetes and asthma. In the upcoming years, these factors are anticipated to accelerate market growth.

Worldwide rising rates of chronic illnesses like COPD, diabetes, and asthma are anticipated to propel the business of connected drug delivery devices. For instance, according to research on estimates of diabetes prevalence for 2021 that was published in January 2022 by the National Library of Medicine and National Center for Biotechnology Information, the disease prevalence among people aged 20 to 79 in 2021 was estimated to be 10.5% and could increase to 12.2% by 2045. Diabetes is thought to affect both men and women equally, however, it is most common in people aged 75 to 79. Additionally, as connected drug delivery devices with greater advantages have become more popular, manual drug administration devices have been increasingly replaced. These factors are anticipated to fuel connected drug market growth.

The global COVID-19 pandemic has had a negative impact and raised the need for healthcare services. This has accelerated the trend of redesigning the healthcare system for improved assistance and quick growth of technology. While most global markets went down in 2020, this market showed unprecedented growth despite difficult conditions and a lockdown in most countries. Due to the lockdown restrictions, there was an unexpected rise in demand for drug delivery systems for use in-home care, which resulted in an increase in demand for connected drug delivery devices.

The report "Connected Drug Delivery Devices Market Size, Share & Trends Analysis Report, By Product (Connected Sensors, Integrated Connected Devices), By Route of Administration (Parenteral, Inhalational), By Application (Asthma, COPD, Diabetes Management), By Region, And Segment Forecasts, 2022-2030" is available now to Grand View Research customers and can also be directly purchased from

Connected Drug Delivery Devices Market Report Highlights

  • The global market was valued at USD 4.84 billion in 2022 and is expected to grow at a CAGR of 23.45% during the forecast period
  • The standalone components and software segment is expected to grow for the highest revenue share during the forecast period, owing to the increasing demand for connected sensors to transform traditional drug delivery devices into connected drug delivery devices without interfering with their normal functioning and can be reused even if the device is disposable
  • The parenteral segment is expected to drive market growth during the forecast period, owing to the numerous advantages offered by smart & connected parenteral devices over conventional ones
  • Diabetes Management dominated the market with a share of over 36.23% in 2022. This is owing to factors such as the rising prevalence of diabetes, technological advancements, and R&D in insulin delivery devices
  • North America is expected to dominate the market over the forecast period. This is due to the region's high per capita healthcare spending, rapid adoption of technology presence of key players, and growing adoption of remote monitoring for medication adherence

Table of Contents

Chapter 1 Research Methodology & Scope

  • 1.1 Market Segmentation & Scope
    • 1.1.1 Estimates & Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased database:
    • 1.3.2 GVR's Internal Database
    • 1.3.3 Secondary sources
    • 1.3.4 Primary Research:
    • 1.3.5 Details of Primary Research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
  • 1.7 List of Secondary Sources
  • 1.8 Objectives

Chapter 2 Executive Summary

  • 2.1 Market Snapshot
  • 2.2 Segment Snapshot
  • 2.3 Competitive Landscape Snapshot

Chapter 3 Connected Drug Delivery Devices Market: Market Variables Trends & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Analysis
    • 3.1.2 Ancillary Market Analysis
  • 3.2 Penetration And Growth Prospect Mapping
  • 3.3 Market Dynamics
    • 3.3.1 Market Driver Analysis
    • 3.3.2 Market Restraint Analysis
    • 3.2.3 Market Opportunity Analysis
    • 3.2.4 Market Challenge Analysis
  • 3.4 Industry Analysis
    • 3.4.1 Porter's 5 Forces Analysis
      • 3.4.1.1 Bargaining Power of Buyers
      • 3.4.1.2 Bargaining Power of Suppliers
      • 3.4.1.3 Threat of New Entrants
      • 3.4.1.4 Threat of Substitutes
      • 3.4.1.5 Industry Rivalry: High
    • 3.4.2 PESTEL ANALYSIS
      • 3.4.2.1 Political & Legal Landscape
      • 3.4.2.2 Economic & Social Landscape
      • 3.4.2.3 Environmental Landscape
      • 3.4.2.4 Technology Landscape
  • 3.5 R&D/ Product Pipeline Analysis
  • 3.6 Pricing Analysis
  • 3.7 Regulatory & Reimbursement Framework
  • 3.8 Connected Drug Delivery Devices Market: Covid-19 Impact Analysis

Chapter 4 Connected Drug Delivery Devices Market: Product Analysis

  • 4.1 Product Market Share Analysis, 2022 & 2030
  • 4.2 Connected Drug Delivery Devices Market: Product movement analysis, 2018 to 2030
  • 4.3 Standalone Components & Software
    • 4.3.1 Standalone Components & Software market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.3.2 Integrated Devices
      • 4.3.2.1 Integrated Devices market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5 Connected Drug Delivery Devices Market: Route of Administration Analysis

  • 5.1 Route of Administration Market Share Analysis, 2022 & 2030
  • 5.2 Connected Drug Delivery Devices Market: Route of Administration movement analysis, 2018 to 2030
  • 5.3 Parenteral
    • 5.3.1 Parenteral market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.3.2 Inhalational
      • 5.3.2.1 Inhalational market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6 Connected Drug Delivery Devices Market: Application Analysis

  • 6.1 Application Market Share Analysis, 2022 & 2030
  • 6.2 Connected Drug Delivery Devices Market: Application movement analysis, 2018 to 2030
  • 6.3 Asthma
    • 6.3.1 Asthma market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.3.2 COPD
      • 6.3.2.1 COPD market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.3.3 Diabetes Management
      • 6.3.3.1 Diabetes Management market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.3.4 Others
      • 6.3.4.1 Others market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7 Connected Drug Delivery Devices Market: Regional Market Analysis, By Product, route of administration, application, distribution channel 2018 - 2030 (USD Million)

  • 7.1 Regional Market Share Analysis, 2022 & 2030
  • 7.2 Regional Market Snapshot
  • 7.3 North America
    • 7.3.1 North America Connected Drug Delivery Devices Market estimates and forecasts by countries, 2018 - 2030 (USD Million)
    • 7.3.2 U.S.
      • 7.3.2.1 U.S. Connected Drug Delivery Devices Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.3.3 Canada
      • 7.3.3.1 Canada Connected Drug Delivery Devices Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.4 Europe
    • 7.4.1 Europe Connected Drug Delivery Devices Market estimates and forecasts by countries, 2018 - 2030 (USD Million)
    • 7.4.2 U.K.
      • 7.4.2.1 U.K. Connected Drug Delivery Devices Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.3 Germany
      • 7.4.3.1 Germany Connected Drug Delivery Devices Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.4 France
      • 7.4.4.1 France Connected Drug Delivery Devices Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.5 Spain
      • 7.4.5.1 Spain Connected Drug Delivery Devices Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.6 Italy
      • 7.4.6.1 Italy Connected Drug Delivery Devices Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5 Asia Pacific
    • 7.5.1 Asia Pacific Connected Drug Delivery Devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.2 Japan
      • 7.5.2.1 Japan Connected Drug Delivery Devices Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.3 China
      • 7.5.3.1 China Connected Drug Delivery Devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.4 India
      • 7.5.4.1 India Connected Drug Delivery Devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.5 Australia
      • 7.5.5.1 Australia Connected Drug Delivery Devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.6 South Korea
      • 7.5.6.1 South Korea Connected Drug Delivery Devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.6 Latin America
    • 7.6.1 Latin America Connected Drug Delivery Devices Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.2 Brazil
      • 7.6.2.1 Brazil Connected Drug Delivery Devices Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.3 Mexico
      • 7.6.3.1 Mexico Connected Drug Delivery Devices Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.4 Argentina
      • 7.6.4.1 Argentina Connected Drug Delivery Devices Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.7 MEA
    • 7.7.1 MEA Connected Drug Delivery Devices market estimates and forecasts by countries, 2018 - 2030 (USD Million)
    • 7.7.2 South Africa
      • 7.7.2.1 South Africa Connected Drug Delivery Devices Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.7.3 Saudi Arabia
      • 7.7.3.1 Saudi Arabia Connected Drug Delivery Devices Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 8 Connected Drug Delivery Devices Market - Competitive Analysis

  • 8.1 Teva Respiratory, Llc
    • 8.1.1 Company Overview
    • 8.1.2 Financial Performance
    • 8.1.3 Product Benchmarking
    • 8.1.4 Strategic Initiatives
  • 8.2 Novo Nordisk A/S
    • 8.2.1 Company Overview
    • 8.2.2 Financial Performance
    • 8.2.3 Product Benchmarking
    • 8.2.4 Strategic Initiatives
  • 8.3 Phillips-Medisize, Llc
    • 8.3.1 Company Overview
    • 8.3.2 Financial Performance
    • 8.3.3 Product Benchmarking
    • 8.3.4 Strategic Initiatives
  • 8.4 Medtronic
    • 8.4.1 Company Overview
    • 8.4.2 Financial Performance
    • 8.4.3 Product Benchmarking
    • 8.4.4 Strategic Initiatives
  • 8.5 Adherium Limited
    • 8.5.1 Company Overview
    • 8.5.2 Financial Performance
    • 8.5.3 Product Benchmarking
    • 8.5.4 Strategic Initiatives
  • 8.6 Tandem Diabetes Care, Inc.
    • 8.6.1 Company Overview
    • 8.6.2 Financial Performance
    • 8.6.3 Product Benchmarking
    • 8.6.4 Strategic Initiatives
  • 8.7 Biocorp
    • 8.7.1 Company Overview
    • 8.7.2 Financial Performance
    • 8.7.3 Product Benchmarking
    • 8.7.4 Strategic Initiatives
  • 8.8 Propeller Health
    • 8.8.1 Company Overview
    • 8.8.2 Product Benchmarking
    • 8.8.3 Strategic Initiatives
  • 8.9 Ypsomed Ag
    • 8.9.1 Company Overview
    • 8.9.2 Financial Performance
    • 8.9.3 Product Benchmarking
    • 8.9.4 Strategic Initiatives
  • 8.10 Aptar Pharma
    • 8.10.1 Company Overview
    • 8.10.2 Financial Performance
    • 8.10.3 Product Benchmarking
    • 8.10.4 Strategic Initiatives
  • 8.11 Market Participation Categorization
  • 8.12 Company market position analysis
  • 8.13 List of Key Companies